Aequs Board Approves ₹650 Cr Equity Infusion via Warrants
Aequs Limited's Board has approved a preferential issue of up to 2,80,71,690 warrants, convertible into equity shares, to its promoter group (Mellwood Trustee Services Private Limited) for approximately ₹650 crore. This infusion, subject to shareholder and regulatory approvals, will see ₹325 crore payable upfront. The proceeds are earmarked for expanding aerospace and consumer capacity, supporting subsidiaries and joint ventures, and bolstering the company's borrowing program. The issue price is ₹231.55 per share, determined as the floor price under SEBI regulations. Upon full conversion, the promoter and promoter group's holding will increase from 59.09% to 60.73%. An Extraordinary General Meeting is scheduled for October 22, 2026, to seek shareholder consent.
Key Highlights
- Promoter group to infuse ₹650 crore via equity warrants.
- ₹325 crore to be paid upfront upon warrant allotment.
- Funds to fuel aerospace and consumer capacity expansion.
- Promoter holding to increase to 60.73% post-conversion.
- Shareholder approval sought via EGM on October 22, 2026.
Price Impact
More from AEQUS